|
Synonym(s):
|
|
|
Requisition Form
|
G-MYCO
|
|
Test Description
|
Susceptibility
to rifampin by agar proportion for M. kansasii
|
|
Pre-Approval Needed
|
N/A
|
|
Supplemental Information Required
|
N/A
|
|
Supplemental Form(s)
|
N/A
|
|
Performed on Specimens from (sources)
|
Pure
isolate from human sources.
|
|
Sample/Specimen Type for Testing
|
M.
kansasii pure isolate in liquid or on solid culture medium.
|
|
Minimum Volume/Size Required
|
- Liquid
culture - 2.0 mL
- Solid
culture - Visible growth, more than a single colony.
|
|
Storage/Preservation Prior to Shipping
|
Ambient
|
|
Transport Medium
|
N/A |
|
Specimen Labeling
|
- Two patient-specific identifiers required (e.g., patient full name, date of birth, Medical record number)
- Identifiers on specimen must exactly match submission form.
|
|
Shipping and Specimen Handling Requirements
|
- Ship according to Dangerous Goods Regulations,
IATA, and/or CFR 49.
- Category
B shipping applies
|
|
Method
|
Agar proportion
susceptibility test interpreted as either susceptible or resistant to a
specific drug at critical concentration recommended by CLSI.
|
|
Turn-around Time
|
14 days
|
|
Interferences/Limitations
|
|
| Common Causes for Rejection
|
-
Mixed cultures
- Isolate cultures other than M. kansasii,
- Insufficient sample
(non-viable/no growth)
|
|
Additional Information
|
- Isolates submitted for this test will be
identified by this laboratory.
- No fee
will be charged for this identification unless identification is requested on
the G-MYCO requisition form.
|